Skip to main content

Dr. Skikne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Skikne's full profile

Already have an account?

  • Office

    3901 Rainbow Blvd
    Kansas City, KS 66160
    Phone+1 913-588-6000

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1979
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1969

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 1978 - 2025

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
    Barry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing
    Barry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Remembering James Cook, Oncology Researchers Receive 2020 NIH Director’s New Innovator Awards, and More
    Remembering James Cook, Oncology Researchers Receive 2020 NIH Director’s New Innovator Awards, and MoreFebruary 1st, 2021